“Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study”, J of Skin, vol. 10, no. 2, p. s737, Mar. 2026, doi: 10.25251/0y59xj91.